Brief: Yichang Hec Changjiang Pharmaceutical Posts HY Revenue Rmb202.2 MLN
Aug 27 (Reuters) - YiChang HEC ChangJiang Pharmaceutical Co
Ltd 1558.HK :
* HY REVENUE WAS RMB202.2 MILLION, DECREASE OF 90.3%
* HY LOSS AND TOTAL COMPREHENSIVE EXPENSE ATTRIBUTABLE RMB
507 MLN
VS PROFIT RMB 617.5 MLN
Source text for Eikon: ID:nHKS87K2Qr
Further company coverage: 1558.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Yichang Hec Changjiang Pharmaceutical Co
See all newsBrief: Yichang Hec Changjiang Pharmaceutical Says Exchange Approved Withdrawal Of Listing Of H Shares
Brief: Yichang Hec Changjiang Pharmaceutical Says Encofosbuvir Tablets (0.3G) Approved For Launch By NMPA
Brief: Yichang HEC Changjiang Pharmaceutical Updates On Filing With Listing Committee
Brief: YiChang HEC Changjiang Pharmaceutical Says Sunshine Lake Pharma To Enter Licensing Agreement
Brief: YiChang HEC Changjiang Pharmaceutical Posts HY Revenue RMB2,454.8 Million